NASDAQ: ATAI
Atai Life Sciences Nv Stock Ownership - Who owns Atai Life Sciences Nv?

Insider buying vs selling

Have Atai Life Sciences Nv insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Apeiron Investment Group Ltd10% Owner2025-08-148,675,799$2.19
$19.00MBuy
Apeiron Investment Group Ltd10% Owner2025-03-241,800,000$1.40
$2.52MBuy
Anne Nagengast JohnsonChief Financial Officer2025-03-2133,545$1.35
$45.29kSell
Sahil KirpekarChief Business Officer2025-03-2148,563$1.35
$65.56kSell
Srinivas RaoCo-Founder and Chief Executive Officer2025-03-2175,418$1.35
$101.81kSell
Glenn Frank ShortChief Scientific Officer2025-03-2113,161$1.35
$17.77kSell
Kevin James CraigChief Medical Officer2025-03-2111,563$1.35
$15.61kSell
Apeiron Investment Group Ltd10% Owner2025-02-1410,835,718$2.10
$22.76MBuy

1 of 1

ATAI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATAI insiders and whales buy or sell their stock.

ATAI Shareholders

What type of owners hold Atai Life Sciences Nv stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Apeiron Investment Group Ltd24.65%52,844,516$241.50MInsider
Christian Angermayer12.97%27,805,200$127.07MInsider
Ubs Group Ag3.59%7,699,759$35.19MInstitution
Adage Capital Partners GP LLC2.54%5,434,782$24.84MInstitution
Morgan Stanley1.63%3,494,292$15.97MInstitution
Pale Fire Capital Se1.23%2,640,384$12.07MInstitution
Millennium Management LLC0.55%1,188,165$5.43MInstitution
Citadel Advisors LLC0.55%1,179,543$5.39MInstitution
Moore Capital Management LP0.44%952,380$4.35MInstitution
Brown University0.34%718,500$3.28MInstitution

1 of 3

ATAI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATAI13.61%38.27%Net BuyingNet Buying
ZYME53.28%46.72%Net BuyingNet Buying
SYRE71.11%28.89%Net Selling
STOK52.23%47.77%Net SellingNet Selling
OCS9.14%0.00%

Atai Life Sciences Nv Stock Ownership FAQ

Who owns Atai Life Sciences Nv?

Atai Life Sciences Nv (NASDAQ: ATAI) is owned by 13.61% institutional shareholders, 38.27% Atai Life Sciences Nv insiders, and 48.12% retail investors. Apeiron Investment Group Ltd is the largest individual Atai Life Sciences Nv shareholder, owning 52.84M shares representing 24.65% of the company. Apeiron Investment Group Ltd's Atai Life Sciences Nv shares are currently valued at $250.48M.

If you're new to stock investing, here's how to buy Atai Life Sciences Nv stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.